Farmaprojects | Polpharma Group

🌍 Reinforcing partnerships in Iraq and Kurdistan. Wassim Altarche Xifró, PhD, PharmD., Key Account Manager, attended EIF Erbil International Fair (MEDICO), a prominent international health exhibition in Iraq and the Kurdistan region, held in Erbil, on the 5-8th of February. This event reinforces our commitment to providing high-quality medicines in the region. It was an excellent opportunity to represent Farmaprojects | Polpharma Group and Polpharma Group and showcase Polpharma’s pharmaceutical products marketed in Iraq. Thanks, Pure Pharma (ESB Group), our B2B distributor in the region, for the invitation. #MEDICO #Farmaprojects #PortfolioStrategy #PartnershipOpportunities

Don’t miss the opportunity!

Exciting update for the days ahead! 🔜 We’ll participate at BePharmaB2B taking place on the 31st of March and 1st of April 2025 in Mexico City. Roberto Asensio and Joan Castanyer Costa are eager to connect with local industry leaders and companies interested in partnering with us. We look forward to engaging with fellow professionals and discovering new opportunities in the field. Will we see you there? #Farmaprojects #BePharma2025 #B2BPharma

How to differentiate in an overcrowded generics market? It's been 40 years since the growth of the generic drug market was fueled in the U.S. The Hatch-Waxman Amendments allowed generic drug manufacturers to demonstrate bioequivalence through pharmacokinetic studies, avoiding clinical trials. 📈 In 1984 only 19% of all prescription drug purchases in the U.S. were generics. 📈 By 2004, this grew to more than 53%. 📈 Today, generic drugs account for more than 90% of prescriptions filled in the U.S. Generics are generics, which means no differentiation. When your product is the same, your service is key. ✅ Go further than simple product development. This means actively listening to and understanding your client's needs. We perform a good market analysis, study market share in our client's relevant markets, and analyze competitor pricing to provide solutions to our customers to improve their market share. We are an agile company backed by the manufacturing resources of the Polpharma Group. We are there for you. Check it out: https://lnkd.in/d9kquK8x #YesYouHealth #Farmaprojects #Polpharma #B2BPharma #R&D #Generics

Our sales team is now equipped with top-notch negotiation tactics and selling strategies. Francesc Aroca, negotiation and leadership expert from MRC International People Training, trained our team on effective selling and negotiation. Skills? Sharpened. Confidence? Boosted. Dedication? Unwavering. 🟨 Yes You Health is not just a tagline. It’s our commitment. With this training, we are more equipped to help everyone achieve their healthcare goals. From customers to patients, from partners to employees. #YesYouHealth #OneTeam #Farmaprojects #Polpharma #TeamCulture #Training #B2BPharma

We are attending #BioEuropeSpring in Milan! Hendrik M., Portfolio Manager, will join forces with Małgorzata Masłowska from Polpharma Group, Project Manager of our external development projects, to connect for innovation. 📍Allianz Milano Convention Centre, Milan 🗓️ 17-19th March Reach out to connect with us to explore new partnerships in differentiated generics, catch up on trends in drug-delivery technology, and how we can collaborate to enable innovation in the field. #BioEuropeSpring #Farmaprojects #PortfolioStrategy #PartnershipOpportunities

Farmaprojects is transforming diabetes care. Our approach ensures equal and easier access to anti-diabetic medicines for patients. Within our commitment to reinforce our Diabetics Portfolio: ✅ We have developed a holistic approach including, the timely availability of EU dossiers for Dapagliflozin, Dapagliflozin + Metformin, Linagliptin, and Empagliflozin by the filing of proactive EU MAs. ✅ We have developed a robust IP approach to ensure that our clients are first to market. Willpower is our hallmark. Yes to make things happen. Yes You Health. #Diabetes #B2BPharma #Portfolio #Farmaprojects 

💊 We are looking for new talent for this position in Farmaprojects, an excellent opportunity to grow and develop in a dynamic environment! 💊

Don't miss the opportunity! In two weeks our team will be in New York City to attend DCAT Week 2025. Bernardo Reiner and Roberto Asensio will be glad to discuss in detail the opportunities and strategic benefits of partnering with Farmaprojects | Polpharma Group ✅ Direct access to the Eastern Europe Market ✅ B2B network with a presence in all major EU markets Farmaprojects can support your pharmaceutical projects through co-developments, in-license of US dossiers with sub-licensing rights, dossier acquisition with tech transfer rights to Poland, and out-licensing of PPH developments in the US. 📍 New York City | Fifty Sonesta, NY 155 East 50th St. #Cornell Penthouse PH2-22nd floor 🗓️ March 17-20th Don't miss it! #DCATWeek #Farmaprojects #PortfolioStrategy #PartnershipOpportunities

Our team is a true reflection of our Yes You Health philosophy. Farmaprojects | Polpharma Group commitment to improving the pharmaceutical industry is clear. We are helping from two fronts: Carmen Guerrero, our Head of Regulatory Affairs, and Nuria Cabello, PhD, our Pharmacovigilance Manager, are making a difference at the Catalan section of AEFI - Asociación Española de Farmacéuticos de la Industria, the Spanish Association of Pharmacists in Industry. This Association focuses on the continuous training of professionals in the pharmaceutical industry. We are committed. We advocate for training. We are at the forefront. We are shaping the future of B2B in the pharmaceutical industry. #AEFI #RegulatoryAffairs #Pharmacovigilance #Farmaprojects